Concepts (237)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Phosphatidylethanolamine N-Methyltransferase | 4 | 2017 | 11 | 1.620 |
Why?
|
| Serine | 4 | 2019 | 174 | 1.350 |
Why?
|
| Methionine | 5 | 2020 | 102 | 1.280 |
Why?
|
| Diet, High-Fat | 3 | 2015 | 206 | 0.640 |
Why?
|
| Mitochondrial Dynamics | 1 | 2018 | 46 | 0.590 |
Why?
|
| Prostatic Neoplasms | 4 | 2024 | 1516 | 0.590 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2019 | 132 | 0.590 |
Why?
|
| Epigenesis, Genetic | 3 | 2024 | 665 | 0.580 |
Why?
|
| Obesity | 4 | 2017 | 2083 | 0.580 |
Why?
|
| ATP-Binding Cassette Transporters | 3 | 2015 | 190 | 0.570 |
Why?
|
| Sarcoma | 1 | 2019 | 197 | 0.560 |
Why?
|
| Metabolomics | 2 | 2019 | 389 | 0.560 |
Why?
|
| Lipid Metabolism | 2 | 2018 | 353 | 0.520 |
Why?
|
| Glucose | 5 | 2019 | 875 | 0.520 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2016 | 165 | 0.500 |
Why?
|
| Vagotomy | 1 | 2014 | 10 | 0.490 |
Why?
|
| Hypothermia | 1 | 2015 | 51 | 0.490 |
Why?
|
| Phosphatidylcholines | 1 | 2014 | 41 | 0.480 |
Why?
|
| Lipogenesis | 1 | 2014 | 59 | 0.470 |
Why?
|
| Disease Models, Animal | 5 | 2019 | 4282 | 0.470 |
Why?
|
| Adipose Tissue, White | 1 | 2014 | 78 | 0.460 |
Why?
|
| Colorectal Neoplasms | 1 | 2019 | 559 | 0.440 |
Why?
|
| Nucleotides | 3 | 2018 | 91 | 0.440 |
Why?
|
| Mitochondria | 1 | 2018 | 666 | 0.430 |
Why?
|
| Cysteine | 3 | 2020 | 132 | 0.430 |
Why?
|
| Liver | 5 | 2020 | 1851 | 0.430 |
Why?
|
| Fatty Liver | 1 | 2014 | 182 | 0.430 |
Why?
|
| Glutamine | 4 | 2023 | 194 | 0.420 |
Why?
|
| Cell Line, Tumor | 10 | 2023 | 3290 | 0.400 |
Why?
|
| Neoplasms | 5 | 2023 | 2753 | 0.400 |
Why?
|
| Energy Metabolism | 2 | 2023 | 747 | 0.390 |
Why?
|
| Glutaminase | 2 | 2022 | 14 | 0.380 |
Why?
|
| Carbon | 4 | 2023 | 90 | 0.380 |
Why?
|
| Animals | 24 | 2024 | 33721 | 0.340 |
Why?
|
| Cholesterol | 2 | 2013 | 521 | 0.330 |
Why?
|
| Citric Acid Cycle | 2 | 2018 | 44 | 0.310 |
Why?
|
| Mice | 16 | 2024 | 17546 | 0.310 |
Why?
|
| Histones | 3 | 2019 | 530 | 0.250 |
Why?
|
| Lipolysis | 2 | 2015 | 82 | 0.240 |
Why?
|
| Diet | 3 | 2024 | 1106 | 0.240 |
Why?
|
| HCT116 Cells | 3 | 2018 | 55 | 0.230 |
Why?
|
| Cystathionine | 1 | 2024 | 5 | 0.230 |
Why?
|
| Androgen Antagonists | 2 | 2023 | 114 | 0.230 |
Why?
|
| Intestinal Neoplasms | 1 | 2024 | 40 | 0.220 |
Why?
|
| Prodrugs | 1 | 2023 | 59 | 0.220 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2024 | 101 | 0.220 |
Why?
|
| Amino Acids, Branched-Chain | 1 | 2023 | 75 | 0.220 |
Why?
|
| Lipoproteins | 2 | 2015 | 178 | 0.220 |
Why?
|
| Glycolysis | 3 | 2019 | 145 | 0.220 |
Why?
|
| Oxidation-Reduction | 3 | 2019 | 445 | 0.210 |
Why?
|
| Prostatic Neoplasms, Castration-Resistant | 1 | 2023 | 85 | 0.210 |
Why?
|
| Drug Resistance, Neoplasm | 3 | 2022 | 717 | 0.210 |
Why?
|
| Fluorouracil | 2 | 2019 | 140 | 0.200 |
Why?
|
| Receptors, Androgen | 2 | 2023 | 408 | 0.190 |
Why?
|
| Humans | 24 | 2024 | 122296 | 0.180 |
Why?
|
| Carcinogenesis | 1 | 2024 | 332 | 0.180 |
Why?
|
| Cell Proliferation | 4 | 2024 | 2311 | 0.180 |
Why?
|
| Hepatocyte Nuclear Factor 4 | 1 | 2020 | 20 | 0.180 |
Why?
|
| Metabolome | 3 | 2020 | 286 | 0.180 |
Why?
|
| Sulfur | 1 | 2019 | 12 | 0.170 |
Why?
|
| Proof of Concept Study | 1 | 2019 | 29 | 0.170 |
Why?
|
| Genes, ras | 1 | 2019 | 96 | 0.160 |
Why?
|
| Mice, Inbred C57BL | 6 | 2019 | 4366 | 0.160 |
Why?
|
| Enzyme Inhibitors | 2 | 2023 | 582 | 0.160 |
Why?
|
| Receptors, Pattern Recognition | 1 | 2019 | 3 | 0.160 |
Why?
|
| Hydro-Lyases | 1 | 2019 | 9 | 0.160 |
Why?
|
| Phosphoglycerate Dehydrogenase | 1 | 2018 | 5 | 0.160 |
Why?
|
| Healthy Volunteers | 1 | 2019 | 130 | 0.160 |
Why?
|
| Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2019 | 20 | 0.160 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2019 | 29 | 0.160 |
Why?
|
| Pentose Phosphate Pathway | 1 | 2018 | 44 | 0.160 |
Why?
|
| Genes, p53 | 1 | 2019 | 215 | 0.160 |
Why?
|
| Glycogen | 1 | 2018 | 63 | 0.160 |
Why?
|
| Cancer-Associated Fibroblasts | 1 | 2018 | 14 | 0.160 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2019 | 108 | 0.150 |
Why?
|
| Glycerophospholipids | 1 | 2018 | 7 | 0.150 |
Why?
|
| HT29 Cells | 1 | 2018 | 45 | 0.150 |
Why?
|
| Sphingolipids | 1 | 2018 | 28 | 0.150 |
Why?
|
| Glyceraldehyde-3-Phosphate Dehydrogenases | 1 | 2017 | 23 | 0.150 |
Why?
|
| Zika Virus | 1 | 2019 | 136 | 0.140 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2023 | 1118 | 0.140 |
Why?
|
| Fluorescent Dyes | 2 | 2008 | 261 | 0.140 |
Why?
|
| Signal Transduction | 3 | 2023 | 4511 | 0.140 |
Why?
|
| Fenofibrate | 1 | 2017 | 57 | 0.140 |
Why?
|
| Zika Virus Infection | 1 | 2019 | 161 | 0.140 |
Why?
|
| Glycoproteins | 1 | 2019 | 371 | 0.130 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2016 | 75 | 0.130 |
Why?
|
| Precision Medicine | 1 | 2019 | 306 | 0.130 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2019 | 398 | 0.130 |
Why?
|
| Male | 10 | 2024 | 59522 | 0.130 |
Why?
|
| Fatty Acids | 1 | 2018 | 337 | 0.130 |
Why?
|
| Multiprotein Complexes | 1 | 2016 | 207 | 0.120 |
Why?
|
| Cold Temperature | 1 | 2015 | 81 | 0.120 |
Why?
|
| Transcription Factor CHOP | 1 | 2014 | 7 | 0.120 |
Why?
|
| Gene Expression Profiling | 2 | 2021 | 1674 | 0.120 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2016 | 178 | 0.120 |
Why?
|
| Macrophages | 2 | 2023 | 611 | 0.120 |
Why?
|
| Models, Biological | 2 | 2017 | 1438 | 0.120 |
Why?
|
| Adipocytes, White | 1 | 2014 | 25 | 0.120 |
Why?
|
| Protective Factors | 1 | 2014 | 82 | 0.120 |
Why?
|
| Vagus Nerve | 1 | 2014 | 43 | 0.120 |
Why?
|
| Ovarian Neoplasms | 1 | 2018 | 413 | 0.120 |
Why?
|
| Heat-Shock Proteins | 1 | 2015 | 194 | 0.120 |
Why?
|
| Chemokine CCL2 | 1 | 2014 | 115 | 0.120 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2013 | 316 | 0.120 |
Why?
|
| Oxygen Consumption | 1 | 2015 | 303 | 0.120 |
Why?
|
| Chemokines | 1 | 2014 | 136 | 0.120 |
Why?
|
| Adipogenesis | 1 | 2014 | 75 | 0.110 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2016 | 428 | 0.110 |
Why?
|
| DNA Methylation | 2 | 2019 | 991 | 0.110 |
Why?
|
| Mice, Knockout | 3 | 2019 | 3770 | 0.110 |
Why?
|
| Protein Transport | 2 | 2013 | 369 | 0.110 |
Why?
|
| Postoperative Period | 1 | 2014 | 330 | 0.110 |
Why?
|
| Interleukin-10 | 1 | 2014 | 170 | 0.110 |
Why?
|
| Lipoylation | 1 | 2013 | 4 | 0.110 |
Why?
|
| Adiposity | 1 | 2014 | 181 | 0.110 |
Why?
|
| Pyrimidines | 1 | 2016 | 375 | 0.110 |
Why?
|
| Down-Regulation | 1 | 2014 | 702 | 0.100 |
Why?
|
| Weight Gain | 1 | 2014 | 382 | 0.100 |
Why?
|
| Homeostasis | 1 | 2016 | 680 | 0.100 |
Why?
|
| Melanoma | 1 | 2019 | 835 | 0.100 |
Why?
|
| Calnexin | 1 | 2011 | 13 | 0.100 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2017 | 387 | 0.100 |
Why?
|
| Chromatography, Gel | 1 | 2011 | 94 | 0.100 |
Why?
|
| Apolipoprotein A-I | 1 | 2011 | 79 | 0.100 |
Why?
|
| Protein Structure, Quaternary | 1 | 2011 | 98 | 0.100 |
Why?
|
| Lipids | 1 | 2014 | 512 | 0.090 |
Why?
|
| Protein Multimerization | 1 | 2011 | 121 | 0.090 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2013 | 356 | 0.090 |
Why?
|
| Conserved Sequence | 1 | 2011 | 291 | 0.090 |
Why?
|
| Genomics | 1 | 2018 | 1458 | 0.090 |
Why?
|
| Amino Acid Substitution | 1 | 2011 | 387 | 0.090 |
Why?
|
| Liver Neoplasms | 1 | 2020 | 1386 | 0.090 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 2 | 2023 | 163 | 0.080 |
Why?
|
| Folic Acid | 2 | 2024 | 291 | 0.080 |
Why?
|
| Ethylenes | 1 | 2008 | 3 | 0.080 |
Why?
|
| Photochemical Processes | 1 | 2008 | 6 | 0.080 |
Why?
|
| Cytokines | 1 | 2014 | 1272 | 0.080 |
Why?
|
| HEK293 Cells | 1 | 2011 | 741 | 0.080 |
Why?
|
| Cell Differentiation | 1 | 2016 | 1935 | 0.080 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2008 | 56 | 0.080 |
Why?
|
| Neurons | 1 | 2019 | 1918 | 0.080 |
Why?
|
| Chromium | 1 | 2008 | 6 | 0.080 |
Why?
|
| Genotype | 1 | 2014 | 2525 | 0.080 |
Why?
|
| Ferrous Compounds | 1 | 2008 | 8 | 0.080 |
Why?
|
| Metabolic Flux Analysis | 2 | 2018 | 12 | 0.080 |
Why?
|
| Rhodamines | 1 | 2008 | 22 | 0.080 |
Why?
|
| Mutation | 2 | 2019 | 5734 | 0.070 |
Why?
|
| Water | 1 | 2008 | 181 | 0.070 |
Why?
|
| Metabolic Networks and Pathways | 2 | 2020 | 184 | 0.070 |
Why?
|
| Tumor Microenvironment | 2 | 2023 | 548 | 0.070 |
Why?
|
| Amino Acid Sequence | 1 | 2011 | 2674 | 0.070 |
Why?
|
| Cells, Cultured | 3 | 2019 | 3074 | 0.070 |
Why?
|
| Molecular Sequence Data | 1 | 2011 | 3865 | 0.070 |
Why?
|
| Cell Movement | 2 | 2020 | 838 | 0.060 |
Why?
|
| Kidney | 1 | 2013 | 1340 | 0.060 |
Why?
|
| Biomarkers | 1 | 2014 | 2933 | 0.060 |
Why?
|
| Phenotype | 1 | 2014 | 4151 | 0.060 |
Why?
|
| Time Factors | 1 | 2014 | 6182 | 0.060 |
Why?
|
| Cystathionine beta-Synthase | 1 | 2024 | 14 | 0.060 |
Why?
|
| Isotopes | 1 | 2023 | 26 | 0.060 |
Why?
|
| Heat-Shock Response | 1 | 2024 | 31 | 0.060 |
Why?
|
| Treatment Outcome | 1 | 2019 | 12045 | 0.060 |
Why?
|
| Nitrogen | 1 | 2023 | 134 | 0.060 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2021 | 1889 | 0.050 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Kinase | 1 | 2023 | 52 | 0.050 |
Why?
|
| Mammals | 1 | 2023 | 261 | 0.050 |
Why?
|
| Leucine | 1 | 2023 | 309 | 0.050 |
Why?
|
| Tissue Array Analysis | 1 | 2021 | 134 | 0.050 |
Why?
|
| Isoenzymes | 1 | 2021 | 222 | 0.040 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2024 | 630 | 0.040 |
Why?
|
| Mesoderm | 1 | 2020 | 116 | 0.040 |
Why?
|
| Middle Aged | 1 | 2019 | 25640 | 0.040 |
Why?
|
| Polyamines | 1 | 2019 | 28 | 0.040 |
Why?
|
| Succinate Dehydrogenase | 1 | 2019 | 7 | 0.040 |
Why?
|
| Hepatitis A Virus Cellular Receptor 2 | 1 | 2019 | 12 | 0.040 |
Why?
|
| Glucose Transporter Type 1 | 1 | 2019 | 24 | 0.040 |
Why?
|
| Nutritional Sciences | 1 | 2019 | 63 | 0.040 |
Why?
|
| Succinates | 1 | 2019 | 20 | 0.040 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2020 | 217 | 0.040 |
Why?
|
| Neuroprotection | 1 | 2019 | 19 | 0.040 |
Why?
|
| Female | 3 | 2020 | 64883 | 0.040 |
Why?
|
| Phosphorylation | 1 | 2023 | 1613 | 0.040 |
Why?
|
| Prostate | 1 | 2021 | 422 | 0.040 |
Why?
|
| MCF-7 Cells | 1 | 2018 | 222 | 0.040 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2021 | 874 | 0.040 |
Why?
|
| Cell Death | 1 | 2019 | 241 | 0.040 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2019 | 104 | 0.040 |
Why?
|
| Coculture Techniques | 1 | 2018 | 235 | 0.040 |
Why?
|
| Histone Code | 1 | 2018 | 52 | 0.040 |
Why?
|
| Methylation | 1 | 2018 | 229 | 0.040 |
Why?
|
| Molecular Structure | 2 | 2008 | 286 | 0.040 |
Why?
|
| Antineoplastic Agents, Immunological | 1 | 2019 | 103 | 0.040 |
Why?
|
| Sesquiterpenes | 1 | 2017 | 22 | 0.040 |
Why?
|
| Lysine | 1 | 2018 | 201 | 0.040 |
Why?
|
| Systems Biology | 1 | 2017 | 61 | 0.040 |
Why?
|
| Lipoproteins, VLDL | 1 | 2017 | 58 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2018 | 697 | 0.030 |
Why?
|
| Mechanistic Target of Rapamycin Complex 2 | 1 | 2016 | 28 | 0.030 |
Why?
|
| Germinal Center | 1 | 2016 | 37 | 0.030 |
Why?
|
| MAP Kinase Signaling System | 1 | 2018 | 320 | 0.030 |
Why?
|
| Ezetimibe | 1 | 2017 | 95 | 0.030 |
Why?
|
| RNA, Viral | 1 | 2019 | 540 | 0.030 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2017 | 122 | 0.030 |
Why?
|
| Computational Biology | 1 | 2021 | 789 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2019 | 799 | 0.030 |
Why?
|
| Immunity, Humoral | 1 | 2016 | 68 | 0.030 |
Why?
|
| Apoptosis | 1 | 2023 | 1790 | 0.030 |
Why?
|
| RNA | 1 | 2019 | 578 | 0.030 |
Why?
|
| Immunoglobulin G | 1 | 2019 | 758 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2016 | 285 | 0.030 |
Why?
|
| Virus Replication | 1 | 2019 | 603 | 0.030 |
Why?
|
| Machine Learning | 1 | 2017 | 207 | 0.030 |
Why?
|
| Molecular Targeted Therapy | 1 | 2017 | 352 | 0.030 |
Why?
|
| Transcription, Genetic | 1 | 2020 | 1703 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2016 | 570 | 0.030 |
Why?
|
| Disease Progression | 1 | 2021 | 1991 | 0.030 |
Why?
|
| RNA-Binding Proteins | 1 | 2019 | 565 | 0.030 |
Why?
|
| Lymphocyte Activation | 1 | 2016 | 680 | 0.030 |
Why?
|
| Triglycerides | 1 | 2017 | 560 | 0.030 |
Why?
|
| Leptin | 1 | 2015 | 209 | 0.030 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2016 | 469 | 0.030 |
Why?
|
| Biomarkers, Tumor | 1 | 2020 | 1424 | 0.030 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2019 | 790 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2013 | 461 | 0.030 |
Why?
|
| Adenosine Triphosphate | 1 | 2013 | 288 | 0.020 |
Why?
|
| Endoplasmic Reticulum | 1 | 2013 | 213 | 0.020 |
Why?
|
| Insulin Resistance | 1 | 2017 | 631 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2013 | 1104 | 0.020 |
Why?
|
| KB Cells | 1 | 2008 | 5 | 0.020 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2008 | 87 | 0.020 |
Why?
|
| Metallocenes | 1 | 2008 | 1 | 0.020 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2008 | 152 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2008 | 330 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2008 | 347 | 0.020 |
Why?
|
| HeLa Cells | 1 | 2008 | 808 | 0.020 |
Why?
|
| Cell Survival | 1 | 2008 | 816 | 0.020 |
Why?
|